110 related articles for article (PubMed ID: 38841300)
1. Case report: Strong GAD antibody positivity and type 1 diabetes-HLA-susceptible haplotype-DRB1*04:05-DQB1*04:01 in a Japanese patient with immune checkpoint inhibitor-induced type 1 diabetes.
Yabuki S; Hirai H; Moriya C; Kusano Y; Hasegawa T
Front Endocrinol (Lausanne); 2024; 15():1407192. PubMed ID: 38841300
[TBL] [Abstract][Full Text] [Related]
2. Type 1 diabetes associated with immune checkpoint inhibitors for malignant melanoma: A case report and review of 8 cases.
Ishiguro A; Ogata D; Ohashi K; Hiki K; Yamakawa K; Jinnai S; Tsutsui K; Takahashi A; Namikawa K; Yamazaki N
Medicine (Baltimore); 2022 Sep; 101(35):e30398. PubMed ID: 36107581
[TBL] [Abstract][Full Text] [Related]
3. Clinical and HLA genotype analysis of immune checkpoint inhibitor-associated diabetes mellitus: a single-center case series from China.
Liu YC; Liu H; Zhao SL; Chen K; Jin P
Front Immunol; 2023; 14():1164120. PubMed ID: 37359544
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.
Yasui J; Kawasaki E; Tanaka S; Awata T; Ikegami H; Imagawa A; Uchigata Y; Osawa H; Kajio H; Kawabata Y; Shimada A; Takahashi K; Yasuda K; Yasuda H; Hanafusa T; Kobayashi T;
PLoS One; 2016; 11(5):e0155643. PubMed ID: 27177031
[TBL] [Abstract][Full Text] [Related]
5. Amino acid polymorphisms in human histocompatibility leukocyte antigen class II and proinsulin epitope have impacts on type 1 diabetes mellitus induced by immune-checkpoint inhibitors.
Inaba H; Morita S; Kosugi D; Asai Y; Kaido Y; Ito S; Hirobata T; Inoue G; Yamamoto Y; Jinnin M; Kimura H; Ota M; Okudaira Y; Nakatani H; Kobayashi T; Iwama S; Arima H; Matsuoka T
Front Immunol; 2023; 14():1165004. PubMed ID: 37114039
[TBL] [Abstract][Full Text] [Related]
6. Glutamic acid decarboxylase 65 and islet cell antigen 512/IA-2 autoantibodies in relation to human leukocyte antigen class II DR and DQ alleles and haplotypes in type 1 diabetes mellitus.
Stayoussef M; Benmansour J; Al-Jenaidi FA; Said HB; Rayana CB; Mahjoub T; Almawi WY
Clin Vaccine Immunol; 2011 Jun; 18(6):990-3. PubMed ID: 21490167
[TBL] [Abstract][Full Text] [Related]
7. Immunogenetic Study of Diabetes Mellitus in Relation to HLA DQ and DR.
Singh G; Singh U; Singh SK; Singh S
Indian J Endocrinol Metab; 2020; 24(4):325-332. PubMed ID: 33088755
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between autoantibodies and HLA-DQ genotypes in patients with type 1 diabetes mellitus].
Wang JP; Zhang C; Lin J; Yuan Y; Zhou HF; Huang G; Zhou M; Zhou ZG
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2380-4. PubMed ID: 18036312
[TBL] [Abstract][Full Text] [Related]
9. HLA Risk Haplotype: Insulin Deficiency in Pediatric Type 1 Diabetes.
Gómez-Díaz RA; Nishimura-Meguro E; Garrido-Magaña E; Lizárraga-Paulin L; Aguilar-Herrera BE; Bekker-Méndez C; Medina-Santillán R; Barquera R; Mondragón-González R; Wacher NH
Rev Invest Clin; 2016; 68(3):128-36. PubMed ID: 27408999
[TBL] [Abstract][Full Text] [Related]
10. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
El-Amir MI; El-Feky MA; Laine AP; Härkönen T; El-Badawy O; Eltayeb AA; El-Melegy TT; Kiviniemi M; Knip M; Ilonen J
Diabetes Metab Res Rev; 2015 Mar; 31(3):287-94. PubMed ID: 25256132
[TBL] [Abstract][Full Text] [Related]
11. Combined immune checkpoint inhibitor therapy with nivolumab and ipilimumab causing acute-onset type 1 diabetes mellitus following a single administration: two case reports.
Zezza M; Kosinski C; Mekoguem C; Marino L; Chtioui H; Pitteloud N; Lamine F
BMC Endocr Disord; 2019 Dec; 19(1):144. PubMed ID: 31870373
[TBL] [Abstract][Full Text] [Related]
12. Fulminant Type 1 Diabetes Mellitus Developed about Half a Year after Discontinuation of Immune Checkpoint Inhibitor Combination Therapy with Nivolumab and Ipilimumab: A Case Report.
Yaura K; Sakurai K; Niitsuma S; Sato R; Takahashi K; Arihara Z
Tohoku J Exp Med; 2021 Aug; 254(4):253-256. PubMed ID: 34373422
[TBL] [Abstract][Full Text] [Related]
13. Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study).
Takeda H; Kawasaki E; Shimizu I; Konoue E; Fujiyama M; Murao S; Tanaka K; Mori K; Tarumi Y; Seto I; Fujii Y; Kato K; Kondo S; Takada Y; Kitsuki N; Kaino Y; Kida K; Hashimoto N; Yamane Y; Yamawaki T; Onuma H; Nishimiya T; Osawa H; Saito Y; Makino H;
Diabetes Care; 2002 Jun; 25(6):995-1001. PubMed ID: 12032105
[TBL] [Abstract][Full Text] [Related]
14. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer.
Godwin JL; Jaggi S; Sirisena I; Sharda P; Rao AD; Mehra R; Veloski C
J Immunother Cancer; 2017; 5():40. PubMed ID: 28515940
[TBL] [Abstract][Full Text] [Related]
15. Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic mucosal melanoma.
Goff CB; Plaxe SC; White W; Dasanu CA
J Oncol Pharm Pract; 2023 Jul; 29(5):1259-1263. PubMed ID: 36734125
[TBL] [Abstract][Full Text] [Related]
16. Case of slowly progressive type 1 diabetes mellitus with drastically reduced insulin secretory capacity after immune checkpoint inhibitor treatment for advanced renal cell carcinoma.
Yamaguchi H; Miyoshi Y; Uehara Y; Fujii K; Nagata S; Obata Y; Kosugi M; Hazama Y; Yasuda T
Diabetol Int; 2021 Apr; 12(2):234-240. PubMed ID: 33786278
[TBL] [Abstract][Full Text] [Related]
17. Similar incidence of type 1 diabetes in two ethnically different populations (Italy and Slovenia) is sustained by similar HLA susceptible/protective haplotype frequencies.
Petrone A; Battelino T; Krzisnik C; Bugawan T; Erlich H; Di Mario U; Pozzilli P; Buzzetti R
Tissue Antigens; 2002 Sep; 60(3):244-53. PubMed ID: 12445307
[TBL] [Abstract][Full Text] [Related]
18. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N
Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268
[TBL] [Abstract][Full Text] [Related]
19. Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese.
Zheng C; Zhou Z; Yang L; Lin J; Huang G; Li X; Zhou W; Wang X; Liu Z
Diabetes Metab Res Rev; 2011 Jan; 27(1):70-8. PubMed ID: 21218510
[TBL] [Abstract][Full Text] [Related]
20. Genetic and diabetic auto-antibody markers in Saudi children with type 1 diabetes.
Manan H; Angham AM; Sitelbanat A
Hum Immunol; 2010 Dec; 71(12):1238-42. PubMed ID: 20858521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
